Production of Recombinant Zika Virus Envelope Protein by Airlift Bioreactor as a New Subunit Vaccine Platform

Production of Recombinant Zika Virus Envelope Protein by Airlift Bioreactor as a New Subunit Vaccine Platform

The Zika Virus (ZIKV) is an emerging arbovirus of great public health concern, particularly in the Americas after its last outbreak in 2015. There are still major challenges regarding disease control, and there is no ZIKV vaccine currently approved for human use. Among many different vaccine platfor...

Full description

Bibliographic Details
Main Authors: Hernan H. M. da Costa, Monica Bielavsky, Diego J. B. Orts, Sergio Araujo, Patrícia P. Adriani, Juliana S. Nogueira, Renato M. Astray, Ramendra P. Pandey, Marcelo Lancellotti, Jair P. Cunha-Junior, Carlos R. Prudencio
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:International Journal of Molecular Sciences
Subjects:
envelope protein
recombinant protein
Zika Virus
rEZIKV
airlift bioreactor
FPLC
Online Access:https://www.mdpi.com/1422-0067/24/18/13955

Internet

https://www.mdpi.com/1422-0067/24/18/13955

Similar Items